Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.68 |
| ▸ | MEN1 | O00255 | 6/20 | 0.68 |
| ▸ | POLB | P06746 | 4/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.68 |
| ▸ | CASP6 | P55212 | 2/20 | 0.68 |
| ▸ | GAA | P10253 | 2/20 | 0.68 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | PKM | P14618 | 2/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | THRB | P10828 | 1/20 | 0.68 |
| ▸ | APEX1 | P27695 | 1/20 | 0.68 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.68 |
| ▸ | RECQL | P46063 | 1/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.68 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.68 |
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Resazurin SCHEMBL29370889 | 0.99 | KMT2A (0.70) | KMT2AMEN1POLBKDM4EMAPK1 | |
| Resazurin SCHEMBL6338 | 0.99 | KMT2A (0.70) | KMT2AMEN1POLBKDM4EMAPK1 | |
| Resazurin SCHEMBL8665938 | 0.99 | KMT2A (0.70) | KMT2AMEN1POLBKDM4EMAPK1 | |
| Resazurin SCHEMBL272629 | 0.97 | KMT2A (0.72) | KMT2AMEN1POLBKDM4EMAPK1 | |
| Resazurin SCHEMBL21823760 | 0.97 | KMT2A (0.68) | KMT2AMEN1POLBKDM4EMAPK1 | |
| Resazurin SCHEMBL29456662 | 0.97 | KMT2A (0.68) | KMT2AMEN1POLBKDM4EMAPK1 | |
| Resazurin SCHEMBL10937342 | 0.97 | KMT2A (0.68) | KMT2AMEN1POLBKDM4EMAPK1 | |
| Resazurin SCHEMBL10638468 | 0.94 | KMT2A (0.65) | KMT2AMEN1POLBKDM4EMAPK1 | |
| Resazurin SCHEMBL20190032 | 0.86 | APP (0.71) | KMT2AMEN1POLBKDM4EMAPK1 | |
| SCHEMBL17921280 | 0.82 | KMT2A (0.49) | KMT2AMEN1POLBKDM4EMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112912491-A | Assays for cell-based therapies or treatments | 加利福尼亚大学董事会 | 2021-06-04 | — | — | CN | claimed |
| US-20210139445-A1 | Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, Display Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-05-13 | — | — | US | claimed |
| CN-118304321-A | Composition for inhibiting glucosyltransferase activity as well as preparation method and application thereof | 武汉简为医疗科技有限公司 | 2024-07-09 | — | — | CN | disclosed |
| EP-4225931-A1 | OXYGEN-INSENSITIVE ELECTROCHEMICAL BIOSENSOR AND METHODS OF USE THEREOF | Trividia Health, Inc. (US) | 2023-08-16 | — | — | EP | disclosed |
| US-20220112536-A1 | OXYGEN-INSENSITIVE ELECTROCHEMICAL BIOSENSOR AND METHODS OF USE THEREOF | TRIVIDIA HEALTH, INC. | 2022-04-14 | — | — | US | disclosed |
| US-20210208130-A1 | ASSAYS FOR CELL-BASED THERAPIES OR TREATMENTS | UNIV CALIFORNIA (US) | 2021-07-08 | — | — | US | disclosed |
| CN-112912491-A | Assays for cell-based therapies or treatments | 加利福尼亚大学董事会 | 2021-06-04 | — | — | CN | disclosed |
| US-20200080979-A1 | METHOD AND DEVICES FOR THE SPECTROPHOTOMETRIC DETERMINATION OF RESIDUAL PHASE TRANSFER CATALYST IN A PET RADIOPHARMACEUTICAL DOSE | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2020-03-12 | — | — | US | disclosed |
| US-20140255984-A1 | MICRO-ORGANISM THREAT DETECTION | ZYZEBA TESTING LIMITED (NZ) | 2014-09-11 | — | — | US | disclosed |
| WO-2012177150-A1 | MICRO-ORGANISM THREAT DETECTION | ZYZEBA TESTING LIMITED (NZ) | 2012-12-27 | — | — | WO | disclosed |
| EP-0927353-B1 | DETECTION OF MICROORGANISMS | SBM LTD (NZ) | 2007-05-09 | — | — | EP | disclosed |
| EP-0927353-A4 | DETECTION OF MICROORGANISMS | SIMMONS MAXINE HELEN (NZ) | 2001-09-12 | — | — | EP | disclosed |
| EP-0927353-A2 | DETECTION OF MICROORGANISMS | Simmons, Maxine Helen (NZ) | 1999-07-07 | — | — | EP | disclosed |
| WO-1998011250-A2 | DETECTION OF MICROORGANISMS | SIMMONS MAXINE HELEN (NZ) | 1998-03-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139445-A1 | Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, Display Device, and Lighting Device | DDT, SLC43A1, SLCO2A1 | KMT2A 2717/4885MEN1 3747/4885POLB 4206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.